The British Heart Foundation (BHF) will tender £30m (€33.2m) to tackle the suffering and devastation caused by...
Up To Date
Latest News
Orphan drug leader Shire plc (Dublin), has received the FDA’s approval for its antibody lanadelumab-flyo,...
Blocking the extracellular matrix (ECM) enzyme leukotriene A4 hydrolase (LTA4H) dampens inflammation but...
Novo Nordisk and Evotec have joined forces to find new drugs in the lucrative diabetes and obesity markets.
French Genkyotex SA has secured an €7.5m gross financing to expand the scope of its Phase II product GKT831 in...